This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Simcere Pharmaceutical R&d Co., Ltd. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Han Shen: Innovator in Pharmaceutical Research
Introduction
Han Shen is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Han Shen holds a patent for 3-pyrrolo[b]cyclohexylene-2-dihydro-indolinone derivatives of formula (I) or their pharmaceutically acceptable salts and uses thereof. This patent also includes intermediates of formula (II) for preparing the above compounds. The bioassay results indicate that these compounds can modulate the activity of protein kinases (PKs), inhibit the activity of tyrosine kinases (PTKs), and inhibit various types of tumor cells. He has 1 patent to his name.
Career Highlights
Han Shen is currently employed at Jiangsu Simcere Pharmaceutical R&D Co., Ltd. His work focuses on innovative drug development and the exploration of new therapeutic agents.
Collaborations
He collaborates with notable colleagues such as Feng Tang and Qiu Jin, contributing to a dynamic research environment.
Conclusion
Han Shen's contributions to pharmaceutical research and his innovative patents highlight his role as a key figure in the development of new therapeutic compounds. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile